Cardiology News and Research

Latest Cardiology News and Research

Researchers identify biomarkers for rare, serious complication in children with COVID-19

The study focused on multisystem inflammatory syndrome in children (MIS-C), an inflammatory response involving multiple organs that can occur weeks after infection with SARS-CoV-2, the virus that causes COVID-19.

31 Aug 2021

Genomic autopsy reveals many genetic variants associated with cardiomyopathy

Postmortem genetic testing, or genomic autopsy, of young individuals who experienced sudden death revealed many had known genetic variants that are associated with cardiomyopathy, according to a Northwestern Medicine study published in JAMA Cardiology.

31 Aug 2021

A single glass of wine can raise the drinker’s risk for atrial fibrillation

A single glass of wine can quickly – significantly – raise the drinker's risk for atrial fibrillation, according to new research by UC San Francisco.

31 Aug 2021

AI approach helps identify heart failure patients who will benefit from beta-blocker therapy

Researchers at the University of Birmingham have developed a new way to identify patients with heart failure who will benefit from treatment with beta-blockers.

31 Aug 2021

New evidence provides strong support for the halt on prescribing hydroxychloroquine for COVID-19

In 2021, in the United States alone, there have been more than 560,000 prescriptions of hydroxychloroquine for the prevention, post-exposure and treatment of COVID-19.

31 Aug 2021

Rescue breathing CPR for pediatric cardiac arrest has superior outcomes, analysis shows

Rescue breathing cardiopulmonary resuscitation (CPR) had superior neurological outcomes compared with compression-only CPR or no CPR at all in infants, children and adolescents, according to a new analysis published today in the Journal of the American College of Cardiology.

30 Aug 2021

Low-sodium alternative for salt lowers stroke risk

Replacing salt with a low-sodium alternative lowers the risk of stroke in people with high blood pressure or prior stroke, according to late breaking research presented in a Hot Line session today at ESC Congress 2021 and published in the New England Journal of Medicine.

30 Aug 2021

Cardiovascular safety of prostate cancer treatments remains unresolved

The relative cardiovascular safety of different types of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the PRONOUNCE trial was terminated early. The late breaking research is presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

Influenza vaccination should become a part of standard hospital care after myocardial infarction

Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

Intensive blood-pressure control benefits older hypertensive patients

Aggressive blood pressure treatment in older hypertensive patients lowers the incidence of cardiovascular events compared to standard therapy, without increasing adverse outcomes. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

Stenting and surgery have similar effects on stroke in patients with severe carotid artery stenosis

Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2021 and published simultaneously in The Lancet.

30 Aug 2021

Combination therapy given in fixed doses can cut risk of cardiovascular disease by more than half

A combination therapy of aspirin, statins and at least two blood pressure medications given in fixed doses can slash the risk of fatal cardiovascular disease (CVD) by more than half, says an international study led by Hamilton researchers.

30 Aug 2021

Screening for atrial fibrillation in the elderly could help avoid stroke and death

Screening for atrial fibrillation in 75- and 76-year-olds could reduce the risk of stroke, severe bleeding and death, according to a study at Karolinska Institutet in Sweden that has been published in the journal The Lancet.

30 Aug 2021

$Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction$

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.

28 Aug 2021

New ESC/EACTS guidelines for the management of valvular heart disease published

The European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery Guidelines for the management of valvular heart disease are published online today in European Heart Journal.

28 Aug 2021

Implantable cardiac monitors effectively detect serious arrhythmias in selected post-infarction patients

Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of serious arrhythmias in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced ejection fraction.

27 Aug 2021

$Analysis shows benefits of empagliflozin in heart failure patients with reduced and preserved ejection fraction$

Analysis shows benefits of empagliflozin in heart failure patients with reduced and preserved ejection fraction

A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction. The late breaking study is presented in a Hot Line session today at ESC Congress 2021 and published in the New England Journal of Medicine.

27 Aug 2021

Hemodynamic-guided management may reduce hospitalizations in patients with earlier stage heart failure

Previous
1
...
68
69
70
71
72
73
74
...
2484
Next

Cardiology News and Research

Latest Cardiology News and Research

Researchers identify biomarkers for rare, serious complication in children with COVID-19

Genomic autopsy reveals many genetic variants associated with cardiomyopathy

A single glass of wine can raise the drinker’s risk for atrial fibrillation

AI approach helps identify heart failure patients who will benefit from beta-blocker therapy

New evidence provides strong support for the halt on prescribing hydroxychloroquine for COVID-19

Rescue breathing CPR for pediatric cardiac arrest has superior outcomes, analysis shows

Low-sodium alternative for salt lowers stroke risk

Cardiovascular safety of prostate cancer treatments remains unresolved

Influenza vaccination should become a part of standard hospital care after myocardial infarction

Intensive blood-pressure control benefits older hypertensive patients

Stenting and surgery have similar effects on stroke in patients with severe carotid artery stenosis

Combination therapy given in fixed doses can cut risk of cardiovascular disease by more than half

Screening for atrial fibrillation in the elderly could help avoid stroke and death

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

New ESC/EACTS guidelines for the management of valvular heart disease published

Implantable cardiac monitors effectively detect serious arrhythmias in selected post-infarction patients

Analysis shows benefits of empagliflozin in heart failure patients with reduced and preserved ejection fraction

Hemodynamic-guided management may reduce hospitalizations in patients with earlier stage heart failure

People living in greener areas less likely to develop cardiovascular disease

Light-to-moderate coffee drinking linked to lower risk of stroke and fatal heart disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cardiology News and Research

Latest Cardiology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in